DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $255 | -100.0% | 1,010 | -72.7% | 0.02% | -77.7% |
| Q2 2021 | $994,000 | +81.4% | 3,704 | +50.3% | 0.11% | +24.4% |
| Q4 2020 | $548,000 | -41.0% | 2,465 | -71.2% | 0.09% | +76.5% |
| Q3 2018 | $929,000 | +55.1% | 8,552 | +40.9% | 0.05% | +70.0% |
| Q2 2018 | $599,000 | -65.2% | 6,071 | -65.5% | 0.03% | -67.0% |
| Q1 2018 | $1,723,000 | +140.6% | 17,600 | +128.3% | 0.09% | +106.8% |
| Q4 2017 | $716,000 | +11.0% | 7,709 | +2.6% | 0.04% | 0.0% |
| Q3 2017 | $645,000 | -65.1% | 7,514 | -65.7% | 0.04% | -63.6% |
| Q2 2017 | $1,849,000 | +20.6% | 21,912 | +22.3% | 0.12% | +47.6% |
| Q1 2017 | $1,533,000 | +12.2% | 17,921 | +2.1% | 0.08% | 0.0% |
| Q4 2016 | $1,366,000 | -51.2% | 17,544 | -41.8% | 0.08% | -40.1% |
| Q4 2015 | $2,801,000 | +49.8% | 30,158 | +37.4% | 0.14% | +48.9% |
| Q3 2015 | $1,870,000 | -13.6% | 21,947 | -13.9% | 0.09% | +7.0% |
| Q1 2015 | $2,165,000 | +174.7% | 25,500 | +177.3% | 0.09% | +56.4% |
| Q4 2014 | $788,000 | +19.8% | 9,196 | +6.3% | 0.06% | +57.1% |
| Q3 2014 | $658,000 | -62.3% | 8,655 | -61.0% | 0.04% | -55.7% |
| Q2 2014 | $1,746,000 | -36.9% | 22,182 | -39.8% | 0.08% | -59.9% |
| Q1 2014 | $2,766,000 | -2.3% | 36,876 | +0.6% | 0.20% | -12.1% |
| Q4 2013 | $2,830,000 | +620.1% | 36,658 | +545.8% | 0.22% | +622.6% |
| Q3 2013 | $393,000 | – | 5,676 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |